tiprankstipranks
Impact BioMedical, Inc. (IBO)
:IBO
US Market
IBO
Impact BioMedical, Inc.
RESEARCH TOOLSreports
Want to see IBO full AI Analyst Report?

Impact BioMedical, Inc. (IBO) Income Statement

107 Followers

Impact BioMedical, Inc. Income Statement

Last quarter (Q4 2025), Impact BioMedical, Inc.'s total revenue was C$7.00K, an increase of Infinity% from the same quarter last year. In Q4, Impact BioMedical, Inc.'s net income was C$5.25M. See Impact BioMedical, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
C$ 32.00KC$ 2.33MC$ 0.00C$ 50.00KC$ 50.00K
Gross Profit
C$ -1.54MC$ 2.33MC$ 0.00C$ 50.00KC$ 50.00K
Operating Expenses
C$ 2.73MC$ 1.78MC$ 4.03MC$ 3.45MC$ 3.45M
Depreciation and Amortization
C$ 1.15MC$ 343.46KC$ 1.12MC$ 1.11MC$ 1.11M
EBITDA
C$ -3.13MC$ -1.54MC$ -2.84MC$ -6.30MC$ -6.30M
Operating Income
C$ -4.27MC$ 551.66KC$ -4.03MC$ -3.40MC$ -3.40M
Other Income/Expenses
C$ -10.18MC$ -2.60MC$ -379.00KC$ -4.47MC$ -4.47M
Pretax Income
C$ -14.45MC$ -2.05MC$ -4.41MC$ -7.88MC$ -7.88M
Net Income
C$ -11.84MC$ -2.05MC$ -4.34MC$ -7.05MC$ -7.05M
Per Share Metrics
Basic EPS
C$ -0.38C$ -0.01C$ -0.01C$ -0.61C$ -0.61
Diluted EPS
C$ -0.38C$ -0.01C$ -0.01C$ -0.61C$ -0.61
Weighted Average Shares Outstanding
 31.55M 41.75M 191.30M 11.50M 11.50M
Weighted Average Shares Outstanding (Diluted)
 31.55M 41.75M 191.30M 11.50M 60.25M
Currency in CAD

Impact BioMedical, Inc. Earnings and Revenue History